Valérie Journot

Self-Reported Symptoms After Initiation of a Protease Inhibitor in HIV-Infected Patients and Their Impact on Adherence to HAART

Ségolène Duran, Bruno Spire, François Raffi et al. · HIV Clinical Trials · 2001 · 219 citations · Full text

Public Health, Pharmacotherapy, Clinical Pharmacology +16

The Dynamic of Adherence to Highly Active Antiretroviral Therapy: Results From the French National APROCO Cohort

Patrizia Carrieri, Valérie Cailleton, Vincent Le Moing et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 184 citations

Public Health, Infectious Diseases, Clinical Pharmacology +16

Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial

Raoul Moh, Delphine Gabillard, Calixte Guéhi et al. · The Lancet Global Health · 2017 · 171 citations · Full text

Medicine, Health Sciences, Pharmacotherapy +12

Once‐Daily Combination Therapy with Emtricitabine, Didanosine, and Efavirenz in Human Immunodeficiency Virus–Infected Patients

Jean‐Michel Molina, F Ferchal, Corinne Rancinan et al. · The Journal of Infectious Diseases · 2000 · 117 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Role of Long-Term Nucleoside-Analogue Therapy in Lipodystrophy and Metabolic Disorders in Human Immunodeficiency Virus--Infected Patients

Geneviève Chêne, E. Angelini, Laurent Cotte et al. · Clinical Infectious Diseases · 2002 · 111 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14